Replies to post #18971 on Radient Pharmaceuticals Corporation fka RXPC

[dcspka]

Lakeshore, I concur with your opinion.

The licensing arrangement is indeed next to worthless and will be modified at the first appropriate opportunity. It was (and continues to be) a stop gap measure.

Wait and see, watch and learn.